Consumers Urge High Court To Hear Tamoxifen Cases

Law360, New York (June 6, 2007, 12:00 AM EDT) -- A group of consumers and unions have reiterated their battle cry for the nation's highest court to take up the tamoxifen citrate antitrust litigation, arguing that the case presents “a straightforward opportunity” to weigh in on the legal issues surrounding authorized generics.

The petitioners said in a supplemental brief filed in the U.S. Supreme Court on Monday that the case, which centers on an authorized generics deal between pharmaceutical companies Barr Pharmaceuticals Inc. and Astrazeneca PLC, gives the High Court the chance to “resolve important legal...
To view the full article, register now.